Pharmacists in Rockland, Maine


13 Pharmacists found in Rockland
male pharmacist

Christopher J Blais, PHARMD


Pharmacist
75 Maverick St Ste 3, Rockland, ME 04841
207-596-6389     207-594-1626

female pharmacist

Grace Li


Pharmacist
75 Maverick St, Rockland, ME 04841
207-596-6389    

male pharmacist

Jacobus Strauss


Pharmacist
28 Park Street, Rockland, ME 04841
207-596-0036    



male pharmacist

Dr. Jonathan Jones, RPH


Pharmacist
28 Park Street, Rockland, ME 04841
207-596-0036    

male pharmacist

Dr. Justin Erik Goodnoe, PHARMD


Pharmacist
28 Park St., Rockland, ME 04841
207-596-0036     207-596-7943

male pharmacist

Kirill Konstantin Goncharov


Pharmacist
75 Maverick St, Rockland, ME 04841
207-596-6389    

female pharmacist

Dr. Lisa Darling, PHARMD


Pharmacist
75 Maverick St Ste 3, Rockland, ME 04841
207-596-6389     207-594-1626

male pharmacist

Dr. Nicholas James Bolognia, PHARM.D


Pharmacist
75 Maverick St Ste 3, Rockland, ME 04841
207-596-6389    

female pharmacist

Rachel Lee, PHARMD


Pharmacist
28 Park Street, Rockland, ME 04841
207-596-0036    

female pharmacist

Ms. Robin Renee Franklin, RPH


Pharmacist
235 Camden St, Rockland, ME 04841
207-594-8070     207-594-8066

male pharmacist

Mr. Rodney Douglas Macdonald, RPH,MS


Pharmacist
235 Camden St, Rockland, ME 04841
207-594-8070     207-594-8066

male pharmacist

Scott D Archer, R.PH.


Pharmacist
28 Park St., Rockland, ME 04841
207-596-0036     207-596-7943

male pharmacist

Dr. Travis J Wilson, PHARM.D.


Pharmacist
235 Camden St, Rockland, ME 04841
207-594-8070    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.